Browsing Tag

CIII

Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA®…

Eli Pacheco Jan 25, 2023 0

Strengthens its Commercial Portfolio with the First and Only AMPA Receptor Antagonist Marketed Product for Epilepsy Bolsters Presence in Neuroscience Expected to be Accretive…

Health

Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel)…

Eli Pacheco Dec 20, 2022 0

Acquisition Expands The Company’s Commercial Portfolio With An Established U.S. Marketed Product Company Remains Dedicated To Growth Within Neurology Through Continued Active Business…

Technology

5G to drive India’s economic growth with improved urban to rural connectivity:…

Andrew McCollum Dec 15, 2022 0

Deloitte India and the Confederation of Indian Industry (CII) project that the Indian telecom industry will grow by $12.5 billion every three years thanks to the adoption of 5G technology.…